Navigating Cell Therapy Manufacturing Amid Pandemic WoesByFeliza MirasolOctober 21st 2020Automation, digitalization, and supply-chain strategies help mitigate vulnerabilities in both autologous and allogeneic cell therapy manufacturing.
Pandemic Drives Digitalization in Bio/Pharma ManufacturingByJennifer MarkarianOctober 21st 2020Automation and tools for remote monitoring are finding increased use as pharmaceutical manufacturing adapts to pandemic restrictions.